ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

June 15, 2007

Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve

February 21, 1975

Tighter Payment Policy

November 5, 2010

Physicians Accept Plans by City of Hope to Pay for Services Through New Foundation

June 3, 2011